Cindy Spittle

Sensitivity of plasma BRAF^mutant and NRAS^mutant cell‐free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non‐RECIST disease progression

Gregory Chang, Jyothirmayee S. Tadepalli, Yongzhao Shao et al. · Molecular Oncology · 2015 · 70 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium

Wen‐Chi Chang, Renata A. Coudry, Margie L. Clapper et al. · Carcinogenesis · 2007 · 65 citations · Full text

Medicine, Oncology, Pathology +17

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression

Xu-Zhi Xu, Marileila Garcia, Tianyu Li et al. · Modern Pathology · 2009 · 49 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Prospective Case-Control Study of Serum Mullerian Inhibiting Substance and Breast Cancer Risk

Joanne F. Dorgan, Frank Z. Stanczyk, Brian L. Egleston et al. · JNCI Journal of the National Cancer Institute · 2009 · 29 citations · Full text

Medicine, Endocrinology, Oncology +13

TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors

Gregory Chang, Jennifer Wiggins, Broderick C. Corless et al. · Journal of Investigative Dermatology · 2020 · 22 citations · Full text

Medicine, Molecular Genetics, Oncology +16